These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9570172

  • 1. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
    Carratalà J, Rosón B, Fernández-Sevilla A, Alcaide F, Gudiol F.
    Arch Intern Med; 1998 Apr 27; 158(8):868-72. PubMed ID: 9570172
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
    Guillamet CV, Vazquez R, Noe J, Micek ST, Kollef MH.
    Medicine (Baltimore); 2016 Aug 27; 95(35):e4708. PubMed ID: 27583907
    [Abstract] [Full Text] [Related]

  • 5. Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia.
    Park SY, Park HJ, Moon SM, Park KH, Chong YP, Kim MN, Kim SH, Lee SO, Kim YS, Woo JH, Choi SH.
    BMC Infect Dis; 2012 Nov 16; 12():308. PubMed ID: 23157735
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
    Kleinhendler E, Cohen MJ, Moses AE, Paltiel O, Strahilevitz J, Cahan A.
    Int J Antimicrob Agents; 2018 Jan 16; 51(1):71-76. PubMed ID: 28705670
    [Abstract] [Full Text] [Related]

  • 8. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters.
    Cheng WL, Hsueh PR, Lee CC, Li CW, Li MJ, Chang CM, Lee NY, Ko WC.
    J Microbiol Immunol Infect; 2016 Apr 16; 49(2):208-15. PubMed ID: 25070279
    [Abstract] [Full Text] [Related]

  • 9. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
    Aparicio J, Oltra A, Llorca C, Montalar J, Herranz C, Gómez-Codina J, Pastor M, Munárriz B.
    Eur J Cancer; 1996 Sep 16; 32A(10):1739-43. PubMed ID: 8983283
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan.
    Huang CC, Wu CJ, Wang LR, Lee HC, Chang CM, Lee NY, Chen TY, Ko WC.
    J Microbiol Immunol Infect; 2011 Oct 16; 44(5):376-81. PubMed ID: 21524977
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
    Carratalá J, Alcaide F, Fernández-Sevilla A, Corbella X, Lińares J, Gudiol F.
    Clin Infect Dis; 1995 May 16; 20(5):1169-73. PubMed ID: 7619995
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP, Nightingale CH, Nicolau DP.
    J Antimicrob Chemother; 2004 Jun 16; 53(6):1098-100. PubMed ID: 15128727
    [Abstract] [Full Text] [Related]

  • 14. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002).
    Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A.
    Medicine (Baltimore); 2005 Sep 16; 84(5):303-312. PubMed ID: 16148730
    [Abstract] [Full Text] [Related]

  • 15. A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
    Ratliff AR, Gentry CA, Williams RJ.
    Diagn Microbiol Infect Dis; 2017 Apr 16; 87(4):376-381. PubMed ID: 28087171
    [Abstract] [Full Text] [Related]

  • 16. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan.
    Lai HP, Hsueh PR, Chen YC, Lee PI, Lu CY, Lu MY, Lin WC, Hsieh YC, Lee CY, Lin KH, Huang LM.
    J Microbiol Immunol Infect; 2003 Sep 16; 36(3):197-202. PubMed ID: 14582565
    [Abstract] [Full Text] [Related]

  • 17. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP.
    Ann Intern Med; 1994 May 15; 120(10):834-44. PubMed ID: 8154643
    [Abstract] [Full Text] [Related]

  • 18. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M, Gallego M, Fontanals D, Mariscal D, Rello J.
    Crit Care Med; 2004 Mar 15; 32(3):625-31. PubMed ID: 15090938
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
    Piérard D, de Meyer A, Lauwers S.
    Pathol Biol (Paris); 1994 May 15; 42(5):471-4. PubMed ID: 7824316
    [Abstract] [Full Text] [Related]

  • 20. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.
    Todeschini G, Franchini M, Tecchio C, Meneghini V, Pizzolo G, Veneri D, Murari C, Ricetti MM, Perona G.
    Int J Infect Dis; 1994 May 15; 3(2):99-104. PubMed ID: 10225988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.